IOVANCE BIOTHERAPEUTICS, INC. Quarterly Other Assets, Noncurrent in USD from Q4 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Iovance Biotherapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2016 to Q2 2024.
  • Iovance Biotherapeutics, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $327K, a 11.2% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $327K +$33K +11.2% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $259K +$57K +28.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $270K +$81K +42.9% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $282K -$314K -52.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $294K -$562K -65.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $202K -$1.06M -84% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $189K -$1.6M -89.4% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $596K -$415K -41% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $856K -$294K -25.6% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $1.27M +$103K +8.86% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $1.78M -$11.1M -86.2% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $1.01M -$2.37M -70.1% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $1.15M -$2.03M -63.9% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $1.16M -$2.32M -66.6% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $12.9M +$9.44M +271% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $3.39M -$10K -0.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $3.18M -$163K -4.87% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $3.48M +$192K +5.84% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $3.48M +$717K +25.9% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $3.4M +$1.06M +45.6% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $3.35M +$1.08M +47.7% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $3.29M +$1.01M +44.5% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $2.76M -$869K -23.9% Dec 31, 2018 10-K 2020-02-25
Q3 2018 $2.33M Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $2.26M Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $2.28M Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $3.63M +$3.63M Dec 31, 2017 10-K 2019-02-28
Q4 2016 $0 Dec 31, 2016 10-K 2018-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.